Yundong He
Shanghai Key Laboratory Of Regulatory Biology
Shanghai, 200241, China
Shanghai, 200241, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Repurposing minocycline to target FOXA1 and its mutants in prostate Cancer.
Journal: Cellular signalling
Published: June 14, 2026
Discovery and biological evaluation of carborane-containing derivatives as TEAD auto palmitoylation inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: January 07, 2025
Discovery of an efficacious KDM5B PROTAC degrader GT-653 up-regulating IFN response genes in prostate cancer.
Journal: European journal of medicinal chemistry
Published: March 18, 2024
Advances in landscape and related therapeutic targets of the prostate tumor microenvironment.
Journal: Acta biochimica et biophysica Sinica
Published: June 09, 2023
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside.
Journal: Signal transduction and targeted therapy
Published: February 23, 2023
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials.
Journal: Signal transduction and targeted therapy
Published: March 12, 2022
Destruction of DNA-Binding Proteins by Programmable Oligonucleotide PROTAC (O'PROTAC): Effective Targeting of LEF1 and ERG.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 16, 2021
SPOP mutation induces replication over-firing by impairing Geminin ubiquitination and triggers replication catastrophe upon ATR inhibition.
Journal: Nature communications
Published: January 29, 2021
Regression of Castration-Resistant Prostate Cancer by a Novel Compound HG122.
Journal: Frontiers in oncology
Published: January 08, 2021
FOXA1 overexpression suppresses interferon signaling and immune response in cancer.
Journal: The Journal of clinical investigation
Published: December 18, 2020
Last Updated: 09/26/2026